Axe Compute Inc. Completes Sale of Helomics to DataMeds

What Happened Axe Compute Inc. announced on Form 8‑K that on September 11, 2026 it sold all issued and outstanding shares of its Helomics subsidiary to DataMeds AI, Inc. The purchase price consisted of 636,328 shares of DataMeds common stock (19.99% of DataMeds outstanding pre‑closing) and a $1,363,672 convertible promissory note with a $1.00 conversion price. The sale closes Axe Compute’s strategic shift to a pure‑play neocloud GPU‑as‑a‑Service company; Helomics was the last operating business remaining from the company’s prior identity as Predictive Oncology.

Key Details

• Closing date: September 11, 2026; press release announcing the transaction issued September 15, 2026.
• Consideration: 636,328 DataMeds shares (19.99% of outstanding pre‑closing) plus a $1,363,672 convertible note (convertible at $1.00/share).
• Transfer restrictions: Consideration shares and shares issuable on conversion are “restricted securities” and subject to a 12‑month lock‑up (transfer only to affiliates or with DataMeds’ consent).
• Other terms: customary reps, covenants and indemnities; Axe Compute agreed to a non‑compete with Helomics’ business and has certain registration rights for the issued securities.
• Lease payment: Axe Compute paid remaining base rent through the current lease terms for two Helomics Pittsburgh premises at closing; obligation limited to base rent only.

Why It Matters This transaction finalizes Axe Compute’s exit from its legacy life‑sciences operations and completes its repositioning as a dedicated GPU cloud service company. Investors should note the form of consideration (equity plus a convertible note), the 12‑month transfer restriction on the received securities, and the non‑compete covenant, all of which affect liquidity and future upside tied to DataMeds. The convertible note’s $1.00 conversion price implies potential share issuance upon conversion (1,363,672 shares if fully converted), which could dilute DataMeds’ capitalization but represents future value potential for Axe Compute.